| Note | HspA5 (heat shock protein A5), also termed immunoglobulin heavy chain binding protein (BiP) or glucose regulated protein with an apparent mass of 78 kDa (Grp78) is a Hsp70-type molecular chaperone of the endoplasmic reticulum (ER). |
| |
| Description | The protein is synthesized as a precursor with an aminoterminal signal peptide of 18 amino acid residues that directs the precursor into the ER. The mature protein (i.e. after removal of the signal peptide by signal peptidase in the ER) contains 635 amino acid residues, including a carboxyterminal ER retention motif that comprises four amino acid residues (KDEL). |
| Expression | The HSPA5 gene is expressed in all nucleated cells, in particular in thyroid-, lung-, smooth muscle-, liver-, and various cells of the immune system. Under cellular stress conditions the gene is over-expressed due to UPR. |
| |  |
| |
| | Central role of HspA5/BiP in gene expression and calcium homeostasis. Typically, BiP is involved in protein transport into and in protein folding and assembly in the ER. Upon protein misfolding -either due to mutation in a client protein or to environmental conditions, such as hypoxia or glucose starvation- one or more proteins start to aggregate and therefore, sequester BiP. This removes BiP from its normal tasks as well as from the signaling molecules in the ER membrane (ATF6, IRE1, PERK). Subsequently, the unfolded protein response/UPR is activated and leads to a reduction of global protein synthesis and the over-production of ER chaperones and ERAD components (ERAD, ER associated protein degradation). If this response fails apoptosis is induced. |
| |
| Localisation | HspA5/BiP is a resident protein of the endoplasmic reticulum (ER). Typically, it is a soluble protein of the lumen of the ER. However, a subfraction of HspA5/BiP can be found on the cell surface of certain cell types, in particular of cancer cells. |
| |  |
| |
| | Interactome of HspA5/BiP. Calcium binding proteins are labeled with red asterisk, membrane proteins are shown in green. ERj, ER protein with j-domain; PDI, protein disulfide isomerase; Grp, glucose regulated protein. |
| |
| Function | The ER is involved in a variety of essential and interconnected processes, including protein biogenesis (protein transport into the ER, protein folding and assembly, and ER associated protein degradation), signal transduction (unfolded protein response/UPR), and calcium homeostasis. The central player in all these processes is the molecular chaperone HspA5/BiP. HspA5/BiP crucially depends on a number of interaction partners, including co-chaperones (ERj1 through ERj7), nucleotide exchange factors (Sil1, Grp170), other chaperones (calnexin, calreticulin, Grp94, UGGT), folding catalysts (protein disulfide isomerases/PDI, and peptidyl prolyl cis/trans isomerases such as Cyclophilin B) and signaling molecules (IRE1, ATF6, PERK, Sigma-1 receptor). As a typical Hsp70, HspA5/BiP comprises an aminoterminal nucleotide binding domain and a carboxyterminal substrate (poly)peptide binding domain. Its functional cycle involves an ATP-form with low affinity for substrate (poly)peptides and an ADP-form with high substrate affinity and is regulated by Hsp40-type co-chaperones and nucleotide exchange factors. Molecular chaperones of the Hsp70 type family reversibly bind to substrate polypeptides via the substrate binding domain (SBD). Typically, Hsp70 substrates are hydrophobic oligopeptides within more or less unfolded polypeptides. The binding of a substrate to the SBD inhibits unproductive interactions of the polypeptide and favors productive folding and assembly that occur concomitant with release from Hsp70. In addition, Hsp70s can regulate the activities of folded polypeptides. |
| |  |
| |
| | Functional cycle of BiP. An unfolded substrate (poly)peptide is shown in red. ADP, adenosine diphosphate; ATP, adenosine triphosphate; NBD, nucleotide binding domain; NEF, nucleotide exchange factor; Pi, inorganic phosphate; SBD, substrate binding domain with lid. |
| |
| Homology | HspA5/BiP belongs to the heat shock protein 70 (Hsp70) family of molecular chaperones. As such it is structurally related to the cytosolic Hsp70s (Hsc70, Hsp70.1, Hsp70.3, Hsp70L1) and the mitochondrial Hsp70 (Grp75/mtHsp75). In addition, HspA5/BiP is structurally related to its nucleotide exchange factor Grp170 that also belongs to the Hsp70 protein family. |
| Note | |
| | |
| Entity | Various cancers such as astrocytoma, breast cancer, glioblastoma, liver cancer, lung cancer, and prostate cancer |
| Note | HspA5/BiP has been linked to various cancers. Due to poor vascularization and the resulting hypoxia and glucose starvation, tumor cells are prone to ER stress and therefore, UPR. In cultured cells, HspA5/BiP is one of the proteins involved in protecting cancer cells against ER stress-induced apoptosis. |
| Disease | HSPA5/BIP expression is highly upregulated in a variety of cancer tissues due to UPR. The HspA5/BiP protects cancer cells against apoptosis through various mechanisms : i) it fights protein aggegation in the ER, ii) due to its ability to bind Ca2+ it prevents calcium signaling in the cytosol, iii) it prevents the activation of pro-apoptotic components, such as BIK, BAX, pro-caspase 7 and pro-caspase 12. Furthermore, HspA5/BiP protects cancer cells against various chemotherapeutic agents that target the same pro-apoptotic components. |
| | |
| | |
| Entity | Haemolytic uraemic syndrome (HUS) |
| Note | HspA5/BiP has been linked to a group of infectious diseases that are caused by Shigella toxin producing E. coli (such as HUS). |
| Disease | Shiga toxigenic Escherichia coli (STEC) strains cause morbidity and mortality. Some of these pathogens produce Shiga toxin and AB5 toxin and are responsible for gastrointestinal diseases, such as HUS. During an infection, the bacterial cytotoxin enters human cells by endocytosis and retrograde transport to the ER. In the ER, BiP is the major target of the catalytic A-subunit, which inactivates BiP by limited proteolysis. Finally, all BiP functions are completely lost, and the affected cells die. |
| | |
| | |
| Entity | Marinesco-Sjogren syndrome (MSS) |
| Note | HspA5/BiP has indirectly been linked to a hereditary disease that is caused by a lack of function of the nucleotide exchange factor of BiP, termed Sil1. |
| | |
| Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. |
| Arap MA, Lahdenranta J, Mintz PJ, Hajitou A, Sarkis AS, Arap W, Pasqualini R. |
| Cancer Cell. 2004 Sep;6(3):275-84. |
| PMID 15380518 |
| |
| Visiting the ER: the endoplasmic reticulum as a target for therapeutics in traffic related diseases. |
| Aridor M. |
| Adv Drug Deliv Rev. 2007 Aug 10;59(8):759-81. Epub 2007 Jun 21. (REVIEW) |
| PMID 17681635 |
| |
| Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas. |
| Bole DG, Hendershot LM, Kearney JF. |
| J Cell Biol. 1986 May;102(5):1558-66. |
| PMID 3084497 |
| |
| Calcium signaling. |
| Clapham DE. |
| Cell. 2007 Dec 14;131(6):1047-58. (REVIEW) |
| PMID 18083096 |
| |
| Functions and pathologies of BiP and its interaction partners. |
| Dudek J, Benedix J, Cappel S, Greiner M, Jalal C, Muller L, Zimmermann R. |
| Cell Mol Life Sci. 2009 May;66(9):1556-69. (REVIEW) |
| PMID 19151922 |
| |
| GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. |
| Fu Y, Li J, Lee AS. |
| Cancer Res. 2007 Apr 15;67(8):3734-40. |
| PMID 17440086 |
| |
| Immunoglobulin heavy chain binding protein. |
| Haas IG, Wabl M. |
| Nature. 1983 Nov 24-30;306(5941):387-9. |
| PMID 6417546 |
| |
| A new role for BiP: closing the aqueous translocon pore during protein integration into the ER membrane. |
| Haigh NG, Johnson AE. |
| J Cell Biol. 2002 Jan 21;156(2):261-70. Epub 2002 Jan 21. |
| PMID 11807091 |
| |
| Interaction of BiP with newly synthesized immunoglobulin light chain molecules: cycles of sequential binding and release. |
| Knittler MR, Haas IG. |
| EMBO J. 1992 Apr;11(4):1573-81. |
| PMID 1563355 |
| |
| Molecular chaperones: multiple functions, pathologies, and potential applications. |
| Macario AJ, Conway de Macario E. |
| Front Biosci. 2007 Jan 1;12:2588-600. (REVIEW) |
| PMID 17127265 |
| |
| ER chaperones in mammalian development and human diseases. |
| Ni M, Lee AS. |
| FEBS Lett. 2007 Jul 31;581(19):3641-51. Epub 2007 Apr 25. (REVIEW) |
| PMID 17481612 |
| |
| AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP. |
| Paton AW, Beddoe T, Thorpe CM, Whisstock JC, Wilce MC, Rossjohn J, Talbot UM, Paton JC. |
| Nature. 2006 Oct 5;443(7111):548-52. |
| PMID 17024087 |
| |
| Endoplasmic reticulum-associated degradation. |
| Romisch K. |
| Annu Rev Cell Dev Biol. 2005;21:435-56. (REVIEW) |
| PMID 16212502 |
| |
| Polypeptide-binding proteins mediate completion of co-translational protein translocation into the mammalian endoplasmic reticulum. |
| Tyedmers J, Lerner M, Wiedmann M, Volkmer J, Zimmermann R. |
| EMBO Rep. 2003 May;4(5):505-10. |
| PMID 12704426 |
| |
| Signaling the unfolded protein response from the endoplasmic reticulum. |
| Zhang K, Kaufman RJ. |
| J Biol Chem. 2004 Jun 18;279(25):25935-8. Epub 2004 Apr 7. (REVIEW) |
| PMID 15070890 |
| |